Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.
Ariel R GreenLiza M ReiflerCynthia M BoydLinda A WeffaldElizabeth A BaylissPublished in: Drugs & aging (2018)
Cardiovascular and CNS-active medications comprise a substantial portion of anticholinergic burden in people with cognitive impairment and multiple chronic conditions. Antidepressants were highly prevalent. Clinical profiles elucidated by these clusters of anticholinergic medications can inform targeted approaches to care.